Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells.

Enguita M, Razquin N, Pamplona R, Quiroga J, Prieto J, Fortes P.

Cell Death Dis. 2019 Jan 8;10(1):14. doi: 10.1038/s41419-018-1243-0.

2.

Duration of untreated illness in a cross-diagnostic sample of obsessive-compulsive disorder, panic disorder, and social anxiety disorder.

Vigne P, Fortes P, Dias RV, Laurito LD, Loureiro CP, de Menezes GB, Stangier U, Fontenelle LF.

CNS Spectr. 2018 Nov 13:1-7. doi: 10.1017/S1092852918001281. [Epub ahead of print]

PMID:
30419984
3.

The use of probiotics for improving lipid profiles in dyslipidemic individuals: an overview protocol.

Fortes PM, Marques SM, Viana KA, Costa LR, Naghettini AV, Costa PS.

Syst Rev. 2018 Oct 17;7(1):165. doi: 10.1186/s13643-018-0826-2.

4.

Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells.

Garitano-Trojaola A, José-Enériz ES, Ezponda T, Unfried JP, Carrasco-León A, Razquin N, Barriocanal M, Vilas-Zornoza A, Sangro B, Segura V, Prósper F, Fortes P, Agirre X.

Oncotarget. 2018 Feb 5;9(16):12842-12852. doi: 10.18632/oncotarget.24401. eCollection 2018 Feb 27.

5.

Regulation of the Interferon Response by lncRNAs in HCV Infection.

Valadkhan S, Fortes P.

Front Microbiol. 2018 Feb 16;9:181. doi: 10.3389/fmicb.2018.00181. eCollection 2018. Review.

6.

Safest Practices for Autologous Buttock Augmentation With Fat Grafting Using a Roller Pump Injection Technique.

Everett M, Morales R Jr, Newall G, Fortes PF, Hustak KL, Patronella CK, Mentz HA 3rd.

Aesthet Surg J. 2018 Jun 13;38(7):751-762. doi: 10.1093/asj/sjx113.

PMID:
29040377
7.

Long Non-coding RNAs in Hepatitis C Virus-Infected Cells.

Barriocanal M, Fortes P.

Front Microbiol. 2017 Sep 28;8:1833. doi: 10.3389/fmicb.2017.01833. eCollection 2017. Review.

8.

Pseudoparalysis of Parrot: A Diagnostic Aid in Congenital Syphilis.

Pereira AA, Castro SM, Venturini RR, César FO, Fortes PM, Costa PS.

J Pediatr. 2017 Nov;190:282. doi: 10.1016/j.jpeds.2017.07.048. Epub 2017 Sep 14. No abstract available.

PMID:
28918883
9.

Social instigation and repeated aggressive confrontations in male Swiss mice: analysis of plasma corticosterone, CRF and BDNF levels in limbic brain areas.

Fortes PM, Albrechet-Souza L, Vasconcelos M, Ascoli BM, Menegolla AP, de Almeida RMM.

Trends Psychiatry Psychother. 2017 Apr-Jun;39(2):98-105. doi: 10.1590/2237-6089-2016-0075. Epub 2017 Jun 12.

10.

Mitral valve aneurysms: Clinical characteristics, echocardiographic abnormalities, and possible mechanisms of formation.

Pena JLB, Bomfim TO, Fortes PRL, Simão-Filho C, de Souza Andrade-Filho J.

Echocardiography. 2017 Jul;34(7):986-991. doi: 10.1111/echo.13556. Epub 2017 May 16.

PMID:
28512734
11.

Response to "Comparing a Propofol Infusion with General Endotracheal Anesthesia in Plastic Surgery Patients".

Morales R Jr, Patronella C, Mentz H 3rd, Newall G, Hustak KL, Fortes P.

Aesthet Surg J. 2017 Apr 1;37(4):NP51-NP52. doi: 10.1093/asj/sjx007. No abstract available.

PMID:
28364530
12.

Cancer stem cell-associated microRNAs: searching for markers and targets in hepatocellular carcinoma.

Hernandez-Alcoceba R, Fortes P.

Transl Gastroenterol Hepatol. 2016 Mar 16;1:16. doi: 10.21037/tgh.2016.03.11. eCollection 2016. No abstract available.

13.

Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.

Tapia CV, Hermosilla G, Fortes P, Alburquenque C, Bucarey S, Salinas H, Rodas PI, Díaz MC, Magne F.

Mycopathologia. 2017 Apr;182(3-4):339-347. doi: 10.1007/s11046-016-0095-3. Epub 2016 Nov 23.

PMID:
27882525
14.

Neuropsychological and behavioral assessment of impulsivity in adolescents: a systematic review.

Willhelm AR, Fortes PM, Czermainski FR, Rates AS, Almeida RM.

Trends Psychiatry Psychother. 2016 Jul-Sep;38(3):128-135. doi: 10.1590/2237-6089-2015-0019. Review.

15.

Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats.

Sobrevals L, Enguita M, Quiroga J, Prieto J, Fortes P.

PLoS One. 2016 Sep 22;11(9):e0162955. doi: 10.1371/journal.pone.0162955. eCollection 2016.

16.

Response to "Concerns Regarding the Use of Oral Anticoagulants (Rivaroxaban and Apixaban) for Venous Thromboembolism Prophylaxis in Plastic Surgery Patients".

Morales R Jr, Ruff E, Patronella C, Mentz H 3rd, Newall G, Hustak KL, Fortes P.

Aesthet Surg J. 2016 Sep;36(8):NP265-8. doi: 10.1093/asj/sjw092. Epub 2016 Jul 20. No abstract available.

PMID:
27439497
17.

Identification of IFN-γ-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure.

Di Scala M, Gil-Fariña I, Olagüe C, Vales A, Sobrevals L, Fortes P, Corbacho D, González-Aseguinolaza G.

Oncotarget. 2016 Aug 2;7(31):49008-49026. doi: 10.18632/oncotarget.10264.

18.

Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication.

Carnero E, Barriocanal M, Prior C, Pablo Unfried J, Segura V, Guruceaga E, Enguita M, Smerdou C, Gastaminza P, Fortes P.

EMBO Rep. 2016 Jul;17(7):1013-28. doi: 10.15252/embr.201541763. Epub 2016 Jun 9.

19.

Racemose neurocysticercosis: a cluster of bad grapes.

Costa PS, Santiago IG, Lima WR, Santos CS, Rocha AV, Fortes PM.

Int J Infect Dis. 2016 Jul;48:5-6. doi: 10.1016/j.ijid.2016.04.012. Epub 2016 Apr 21. No abstract available.

20.

Safety and Efficacy of Novel Oral Anticoagulants vs Low Molecular Weight Heparin for Thromboprophylaxis in Large-Volume Liposuction and Body Contouring Procedures.

Morales R Jr, Ruff E, Patronella C, Mentz H 3rd, Newall G, Hustak KL, Fortes P, Bush A.

Aesthet Surg J. 2016 Apr;36(4):440-9. doi: 10.1093/asj/sjv243.

PMID:
26961988
21.

HCV infection, IFN response and the coding and non-coding host cell genome.

Carnero E, Fortes P.

Virus Res. 2016 Jan 2;212:85-102. doi: 10.1016/j.virusres.2015.10.001. Epub 2015 Oct 8. Review.

PMID:
26454190
22.

Long noncoding RNAs in viral infections.

Fortes P, Morris KV.

Virus Res. 2016 Jan 2;212:1-11. doi: 10.1016/j.virusres.2015.10.002. Epub 2015 Oct 23. Review.

23.

Economic crisis and counter-reform of universal health care systems: Spanish case.

Fortes PA, Carvalho RR, Louvison MC.

Rev Saude Publica. 2015;49:34.

24.

U1 interference (U1i) for antiviral approaches.

Blázquez L, Fortes P.

Adv Exp Med Biol. 2015;848:51-69. doi: 10.1007/978-1-4939-2432-5_3. Review.

PMID:
25757615
25.

Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor Tetherin.

Barriocanal M, Carnero E, Segura V, Fortes P.

Front Immunol. 2015 Jan 9;5:655. doi: 10.3389/fimmu.2014.00655. eCollection 2014.

26.

Type I Interferon Regulates the Expression of Long Non-Coding RNAs.

Carnero E, Barriocanal M, Segura V, Guruceaga E, Prior C, Börner K, Grimm D, Fortes P.

Front Immunol. 2014 Nov 6;5:548. doi: 10.3389/fimmu.2014.00548. eCollection 2014.

27.

Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.

Enguita-Germán M, Fortes P.

World J Hepatol. 2014 Oct 27;6(10):716-37. doi: 10.4254/wjh.v6.i10.716. Review.

28.

Negative regulation of the interferon response by an interferon-induced long non-coding RNA.

Kambara H, Niazi F, Kostadinova L, Moonka DK, Siegel CT, Post AB, Carnero E, Barriocanal M, Fortes P, Anthony DD, Valadkhan S.

Nucleic Acids Res. 2014;42(16):10668-80. doi: 10.1093/nar/gku713. Epub 2014 Aug 13.

29.

[Reflections on public-private participation in healthcare].

Carvalho RR, Fortes PA, Garrafa V.

Salud Publica Mex. 2014 Apr;56(2):221-5. Spanish.

30.

iHWG-μNIR: a miniaturised near-infrared gas sensor based on substrate-integrated hollow waveguides coupled to a micro-NIR-spectrophotometer.

Rohwedder JJ, Pasquini C, Fortes PR, Raimundo IM, Wilk A, Mizaikoff B.

Analyst. 2014 Jul 21;139(14):3572-6. doi: 10.1039/c4an00556b.

PMID:
24867650
31.

Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.

Alzuguren P, Hervas-Stubbs S, Gonzalez-Aseguinolaza G, Poutou J, Fortes P, Mancheno U, Bunuales M, Olagüe C, Razquin N, Van Rooijen N, Enguita M, Hernandez-Alcoceba R.

Liver Int. 2015 Apr;35(4):1274-89. doi: 10.1111/liv.12571. Epub 2014 May 10.

PMID:
24754307
32.

Monitoring of hydrogen sulfide via substrate-integrated hollow waveguide mid-infrared sensors in real-time.

Petruci JF, Fortes PR, Kokoric V, Wilk A, Raimundo IM Jr, Cardoso AA, Mizaikoff B.

Analyst. 2014 Jan 7;139(1):198-203. doi: 10.1039/c3an01793a. Epub 2013 Nov 21.

PMID:
24256718
33.

Supplemental care from a bioethical perspective.

Carvalho RR, Fortes PA, Garrafa V.

Rev Assoc Med Bras (1992). 2013 Nov-Dec;59(6):600-6. doi: 10.1016/j.ramb.2013.06.017. Epub 2013 Nov 9. English, Portuguese.

34.

Real-time monitoring of ozone in air using substrate-integrated hollow waveguide mid-infrared sensors.

da Silveira Petruci JF, Fortes PR, Kokoric V, Wilk A, Raimundo IM, Cardoso AA, Mizaikoff B.

Sci Rep. 2013 Nov 11;3:3174. doi: 10.1038/srep03174.

35.

[Meeting Report: 20 years after the First International Symposium on hepatitis C virus and related viruses].

Carnero E, Díez J, Fortes P, Gastaminza P, Majano P, Martínez MA, Pérez-del-Pulgar S, Quer J, López-Labrador FX; Grupo de Estudio de Hepatitis Víricas de la Sociedad Española de Virología.

Gastroenterol Hepatol. 2013 Dec;36(10):641-6. doi: 10.1016/j.gastrohep.2013.06.001. Epub 2013 Sep 5. Spanish.

PMID:
24011709
36.

Long non-coding RNAs in haematological malignancies.

Garitano-Trojaola A, Agirre X, Prósper F, Fortes P.

Int J Mol Sci. 2013 Jul 24;14(8):15386-422. doi: 10.3390/ijms140815386. Review.

37.

Editing liver tumours.

Colnot S, Fortes P.

Gut. 2014 May;63(5):709-10. doi: 10.1136/gutjnl-2013-305334. Epub 2013 Jul 22. No abstract available.

PMID:
23878166
38.

In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs.

Blázquez L, Aiastui A, Goicoechea M, Martins de Araujo M, Avril A, Beley C, García L, Valcárcel J, Fortes P, López de Munain A.

Hum Mutat. 2013 Oct;34(10):1387-95. doi: 10.1002/humu.22379. Epub 2013 Aug 7.

PMID:
23864287
39.

PrP(C) regulates epidermal growth factor receptor function and cell shape dynamics in Neuro2a cells.

Llorens F, Carulla P, Villa A, Torres JM, Fortes P, Ferrer I, del Río JA.

J Neurochem. 2013 Oct;127(1):124-38. doi: 10.1111/jnc.12283. Epub 2013 May 28.

40.
41.

Patient prioritization in medical emergencies: an ethical analysis.

Fortes PA, Pereira PC.

Rev Assoc Med Bras (1992). 2012 May-Jun;58(3):335-40. English, Portuguese.

42.

Design of modified U1i molecules against HIV-1 RNA.

Knoepfel SA, Abad A, Abad X, Fortes P, Berkhout B.

Antiviral Res. 2012 Jun;94(3):208-16. doi: 10.1016/j.antiviral.2012.03.010. Epub 2012 Apr 7.

PMID:
22507247
43.

Increased in vivo inhibition of gene expression by combining RNA interference and U1 inhibition.

Blazquez L, Gonzalez-Rojas SJ, Abad A, Razquin N, Abad X, Fortes P.

Nucleic Acids Res. 2012 Jan;40(1):e8. doi: 10.1093/nar/gkr956. Epub 2011 Nov 15.

44.

MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.

Bitarte N, Bandres E, Boni V, Zarate R, Rodriguez J, Gonzalez-Huarriz M, Lopez I, Javier Sola J, Alonso MM, Fortes P, Garcia-Foncillas J.

Stem Cells. 2011 Nov;29(11):1661-71. doi: 10.1002/stem.741.

45.

AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers.

Sobrevals L, Enguita M, Rodriguez C, Gonzalez-Rojas J, Alzaguren P, Razquin N, Prieto J, Fortes P.

Gene Ther. 2012 Apr;19(4):411-7. doi: 10.1038/gt.2011.119. Epub 2011 Aug 18.

PMID:
21850051
46.

Comparative analysis of lipid and glucose metabolism biomarkers in non-diabetic hemodialysis and peritoneal dialysis patients.

de Moraes TP, Fortes PC, Ribeiro SC, Riella MC, Pecoits-Filho R.

J Bras Nefrol. 2011 Apr-Jun;33(2):173-9. English, Portuguese.

47.

Cadmium telluride nanocrystals as luminescent sensitizers in flow analysis.

Fortes PR, Frigerio C, Silvestre CI, Santos JL, Lima JL, Zagatto EA.

Talanta. 2011 Jun 15;84(5):1314-7. doi: 10.1016/j.talanta.2011.02.041. Epub 2011 Mar 4.

48.

Adenovirus and miRNAs.

Carnero E, Sutherland JD, Fortes P.

Biochim Biophys Acta. 2011 Nov-Dec;1809(11-12):660-7. doi: 10.1016/j.bbagrm.2011.05.004. Epub 2011 May 17. Review.

PMID:
21621026
49.

AAV-mediated in vivo knockdown of luciferase using combinatorial RNAi and U1i.

Koornneef A, van Logtenstein R, Timmermans E, Pisas L, Blits B, Abad X, Fortes P, Petry H, Konstantinova P, Ritsema T.

Gene Ther. 2011 Sep;18(9):929-35. doi: 10.1038/gt.2011.41. Epub 2011 Apr 7.

50.

Ovary development and maturation in Nezara viridula (L.) (Hemiptera: Pentatomidae).

Fortes P, Salvador G, Cônsoli FL.

Neotrop Entomol. 2011 Jan-Feb;40(1):89-96.

Supplemental Content

Loading ...
Support Center